Structured Summary
Abstract
A macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
15 entry terms
- Spiramycine
- Antibiotic 799
- IL-5902
- NSC-55926
- NSC-64393
- Rovamycin
- Rovamycine
- Selectomycin
- Spiramycin Adipate
- IL 5902
- IL5902
- NSC 55926
- NSC 64393
- NSC55926
- NSC64393
MeSH Record
Aspects Covered
26 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
Indexing Annotation
do not use /biosyn unless by living matter
MeSH Record
History Note
90; was see LEUCOMYCINS 1981-89; was heading 1963-80
MeSH Record
Previous Indexing
- Leucomycins (1981-1989)
MeSH Hierarchy
Tree Number
AMA Style
References
- National Library of Medicine. Spiramycin. Medical Subject Headings (MeSH). 2026. Unique ID D015572. http://id.nlm.nih.gov/mesh/2026/D015572
- Spiramycin. In: Wikipedia. https://en.wikipedia.org/wiki/Spiramycin
- Spiramycin. In: Wikidata. https://www.wikidata.org/wiki/Q422265